Prelude Therapeutics Announces First Quarter 2023 Financial Results and Operations Update

Go back to Prelude Therapeutics Announces First Quarter 2023 Financial Results and Operations Update
(NASDAQ: PRLD) Delayed: 5.25 -0.18 (3.31%)
Previous Close $5.43    52 Week High
Open $5.44    52 Week Low
Day High $5.62    P/E N/A 
Day Low $5.11    EPS
Volume 577,963